世界のウイルスベクター・プラスミドDNA製造市場2021-2027:ベクター種類別、エンドユーザー別、用途別、地域別

Bizwit Research & Consultingが発行した調査報告書(BZW21NO215)
◆英語タイトル:Global Viral Vectors And Plasmid DNA Manufacturing Market Size study, by Vector type (Adenovirus, Retrovirus, Adeno-associated Virus (AAV), Lentivirus, Plasmid DNA, Others), by End-use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), by Application (Antisense & RNAi Therapy, Gene Therapy, Vaccinology, Research Applications), and Regional Forecasts 2021-2027
◆商品コード:BZW21NO215
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2021年10月12日
◆ページ数:約200
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥633,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥800,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。

Bizwit Research社はウイルスベクター・プラスミドDNA製造の世界市場規模が2020年に22億ドルに達し、2021年から2027年までに18.8%成長すると予想しています。本市場調査レポートでは、世界のウイルスベクター・プラスミドDNA製造市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、ベクター種類別(アデノウイルス、レトロウイルス、アデノ随伴ウイルス(AAV)、レンチウイルス、プラスミドDNA)分析、エンドユーザー別(製薬企業・バイオ製薬企業、研究機関)分析、用途別(アンチセンス・RNAi療法、遺伝子治療、ワクチン、研究用)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・ウイルスベクター・プラスミドDNA製造の世界市場規模:ベクター種類別(アデノウイルス、レトロウイルス、アデノ随伴ウイルス(AAV)、レンチウイルス、プラスミドDNA)
・ウイルスベクター・プラスミドDNA製造の世界市場規模:エンドユーザー別(製薬企業・バイオ製薬企業、研究機関)
・ウイルスベクター・プラスミドDNA製造の世界市場規模:用途別(アンチセンス・RNAi療法、遺伝子治療、ワクチン、研究用)
・ウイルスベクター・プラスミドDNA製造の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Viral Vectors and Plasmid DNA Manufacturing Market is valued approximately at USD 2.2 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 18.8% over the forecast period 2021-2027. The global viral vectors and plasmid DNA manufacturing market is being driven by growth in funding for R&D activities pertaining to gene therapy, growth in prevalence of cancer, viral infections, and genetic disorders as well as increase in awareness regarding gene therapies. Furthermore, increase in demand for synthetic genes, will provide new opportunities for the global viral vectors and plasmid DNA manufacturing industry.

For instance, according to national cancer institutes in year 2018, there were around 18.1 million new cases and 9.5 million cancer-related deaths across the world. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. As a result, increased in prevalence of cancer cases will necessitate the use of viral vectors and plasmid DNA manufacturing will serve as a catalyst for the viral vectors and plasmid DNA Manufacturing industry in the future. However, high cost associated with gene therapies, risk of mutagenesis and other impediments in gene therapy may impede market growth over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis of viral vectors and plasmid DNA manufacturing. The presence of a substantial number of centers and institutes that are engaged in the R&D of advanced therapies and increase in regulatory approvals makes the North America the the leading region across the world in terms of market share. Whereas North America is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due growing private and government investments, and increasing healthcare needs in the region.

Major market player included in this report are:
Merck KGaA
Lonza.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra biologics ltd.
Thermo fisher scientific inc.
Waisman Biomanufacturing
Genezen laboratories
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL inc.)
Novasep holding s.a.s.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Vector Type:
Adenovirus
Retrovirus
Adeno-associated Virus (AAV)
Lentivirus
Plasmid DNA
Others

By End-use:
Pharmaceutical and Biopharmaceutical Companies
Research Institutes

By Application:
Antisense & RNAi Therapy
Gene Therapy
Vaccinology
Research Applications

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Viral Vectors And Plasmid DNA Manufacturing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Viral Vectors And Plasmid DNA Manufacturing Market , by Region, 2019-2027 (USD Billion)
1.2.2. Viral Vectors And Plasmid DNA Manufacturing Market , by Vector Type, 2019-2027 (USD Billion)
1.2.3. Viral Vectors And Plasmid DNA Manufacturing Market , by End Use, 2019-2027 (USD Billion)
1.2.4. Viral Vectors And Plasmid DNA Manufacturing Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Viral Vectors And Plasmid DNA Manufacturing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Viral Vectors And Plasmid DNA Manufacturing Market Dynamics
3.1. Viral Vectors And Plasmid DNA Manufacturing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase in funding for R&D activities pertaining to gene therapy
3.1.1.2. Rise in prevalence of cancer, viral infections, and genetic disorders
3.1.1.3. Increase in awareness regarding gene therapies
3.1.2. Market Restraint
3.1.2.1. High cost associated with gene therapies
3.1.2.2. Risk of mutagenesis and other impediments in gene therapy
3.1.3. Market Opportunities
3.1.3.1. Increase in demand for synthetic genes
Chapter 4. Global Viral Vectors And Plasmid DNA Manufacturing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Viral Vectors And Plasmid DNA Manufacturing Market , by Vector Type
5.1. Market Snapshot
5.2. Global Viral Vectors And Plasmid DNA Manufacturing Market by Vector Type, Performance – Potential Analysis
5.3. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by Vector Type 2018-2027 (USD Billion)
5.4. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
5.4.1. Adenovirus
5.4.2. Retrovirus
5.4.3. Adeno-associated Virus (AAV)
5.4.4. Lentivirus
5.4.5. Plasmid DNA
5.4.6. Others
Chapter 6. Global Viral Vectors And Plasmid DNA Manufacturing Market , by End Use
a. Market Snapshot
6.1. Global Viral Vectors And Plasmid DNA Manufacturing Market by End Use, Performance – Potential Analysis
6.2. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by End Use2018-2027 (USD Billion)
6.3. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
6.3.1. Pharmaceutical and Biopharmaceutical Companies
6.3.2. Research Institutes
Chapter 7. Global Viral Vectors And Plasmid DNA Manufacturing Market , by Application
b. Market Snapshot
7.1. Global Viral Vectors And Plasmid DNA Manufacturing Market by Application, Performance – Potential Analysis
7.2. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
7.3.1. Antisense & RNAi Therapy
7.3.2. Gene Therapy
7.3.3. Vaccinology
7.3.4. Research Applications
Chapter 8. Global Viral Vectors And Plasmid DNA Manufacturing Market , Regional Analysis
8.1. Viral Vectors And Plasmid DNA Manufacturing Market , Regional Market Snapshot
8.2. North America Viral Vectors And Plasmid DNA Manufacturing Market
8.2.1. U.S. Viral Vectors And Plasmid DNA Manufacturing Market
8.2.1.1. Vector Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. End Use breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Viral Vectors And Plasmid DNA Manufacturing Market
8.3. Europe Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.3.1. U.K. Viral Vectors And Plasmid DNA Manufacturing Market
8.3.2. Germany Viral Vectors And Plasmid DNA Manufacturing Market
8.3.3. France Viral Vectors And Plasmid DNA Manufacturing Market
8.3.4. Spain Viral Vectors And Plasmid DNA Manufacturing Market
8.3.5. Italy Viral Vectors And Plasmid DNA Manufacturing Market
8.3.6. Rest of Europe Viral Vectors And Plasmid DNA Manufacturing Market
8.4. Asia-Pacific Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.4.1. China Viral Vectors And Plasmid DNA Manufacturing Market
8.4.2. India Viral Vectors And Plasmid DNA Manufacturing Market
8.4.3. Japan Viral Vectors And Plasmid DNA Manufacturing Market
8.4.4. Australia Viral Vectors And Plasmid DNA Manufacturing Market
8.4.5. South Korea Viral Vectors And Plasmid DNA Manufacturing Market
8.4.6. Rest of Asia Pacific Viral Vectors And Plasmid DNA Manufacturing Market
8.5. Latin America Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.5.1. Brazil Viral Vectors And Plasmid DNA Manufacturing Market
8.5.2. Mexico Viral Vectors And Plasmid DNA Manufacturing Market
8.6. Rest of The World Viral Vectors And Plasmid DNA Manufacturing Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Merck KGaA
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Lonza.
9.2.3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.2.4. Cobra biologics ltd.
9.2.5. Thermo fisher scientific inc.
9.2.6. Waisman Biomanufacturing
9.2.7. Genezen laboratories
9.2.8. YPOSKESI
9.2.9. Advanced BioScience Laboratories, Inc. (ABL inc.)
9.2.10. Novasep holding s.a.s.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 2. Global Viral Vectors And Plasmid DNA Manufacturing Market , report scope
TABLE 3. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by Vector Type 2018-2027 (USD Billion)
TABLE 5. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by End Use2018-2027 (USD Billion)
TABLE 6. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 7. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Viral Vectors And Plasmid DNA Manufacturing Market .
TABLE 78. List of primary sources used in the study of global Viral Vectors And Plasmid DNA Manufacturing Market .
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.

List of figures
FIG 1. Global Viral Vectors And Plasmid DNA Manufacturing Market , research methodology
FIG 2. Global Viral Vectors And Plasmid DNA Manufacturing Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Viral Vectors And Plasmid DNA Manufacturing Market , key trends 2020
FIG 5. Global Viral Vectors And Plasmid DNA Manufacturing Market , growth prospects 2021-2027
FIG 6. Global Viral Vectors And Plasmid DNA Manufacturing Market , porters 5 force model
FIG 7. Global Viral Vectors And Plasmid DNA Manufacturing Market , pest analysis
FIG 8. Global Viral Vectors And Plasmid DNA Manufacturing Market , value chain analysis
FIG 9. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Viral Vectors And Plasmid DNA Manufacturing Market , regional snapshot 2018 & 2027
FIG 18. North America Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 19. Europe Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 22. Global Viral Vectors And Plasmid DNA Manufacturing Market , company market share analysis (2020)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のウイルスベクター・プラスミドDNA製造市場2021-2027:ベクター種類別、エンドユーザー別、用途別、地域別(Global Viral Vectors And Plasmid DNA Manufacturing Market Size study, by Vector type (Adenovirus, Retrovirus, Adeno-associated Virus (AAV), Lentivirus, Plasmid DNA, Others), by End-use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), by Application (Antisense & RNAi Therapy, Gene Therapy, Vaccinology, Research Applications), and Regional Forecasts 2021-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆